Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P04836

Entry ID Method Resolution Chain Position Source
AF-P04836-F1 Predicted AlphaFoldDB

30 variants for P04836

Variant ID(s) Position Change Description Diseaes Association Provenance
rs456742286 25 A>P No EVA
rs470515301 26 E>V No EVA
rs432802035 35 A>G No EVA
rs1116425083 58 L>P No EVA
rs452638483 100 E>* No EVA
rs473131322 148 T>P No EVA
rs455392821 160 G>A No EVA
rs441760506 160 G>R No EVA
rs475208122 161 F>L No EVA
rs443795754 165 A>P No EVA
rs458125194 170 E>D No EVA
255 Y>H No
rs463982368 278 Q>H No EVA
rs439557610 279 S>I No EVA
rs471010720 279 S>R No EVA
rs434206233 304 D>E No EVA
rs434699463 368 I>L No EVA
rs435183101 373 R>Q No EVA
rs1114781374 380 R>Q No EVA
rs444465262 406 D>Y No EVA
rs210567645 414 V>I No EVA
rs716791655 425 P>L No EVA
rs475569712 446 F>I No EVA
rs444347458 453 E>K No EVA
rs451574662 453 E>V No EVA
rs471422638 456 E>D No EVA
rs439564363 458 E>D No EVA
rs439969348 460 E>A No EVA
rs460239686 466 W>C No EVA
rs442450617 476 F>Q No EVA

No associated diseases with P04836

3 regional properties for P04836

Type Name Position InterPro Accession
domain Activin types I and II receptor domain 28 - 111 IPR000472
domain Protein kinase domain 190 - 481 IPR000719
active_site Serine/threonine-protein kinase, active site 318 - 330 IPR008271

Functions

Description
EC Number 3.4.17.10 Metallocarboxypeptidases
Subcellular Localization
  • Cytoplasmic vesicle, secretory vesicle
  • Cytoplasmic vesicle, secretory vesicle membrane ; Peripheral membrane protein
  • Secreted
  • Associated with the secretory granule membrane through direct binding to lipid rafts in intragranular conditions
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
extracellular space That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
Golgi apparatus A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.
secretory granule membrane The lipid bilayer surrounding a secretory granule.
transport vesicle membrane The lipid bilayer surrounding a transport vesicle.

4 GO annotations of molecular function

Name Definition
cell adhesion molecule binding Binding to a cell adhesion molecule.
metallocarboxypeptidase activity Catalysis of the hydrolysis of a single C-terminal amino acid residue from a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
neurexin family protein binding Binding to a neurexin, a synaptic cell surface protein related to latrotoxin receptor, laminin and agrin. Neurexins act as cell recognition molecules at nerve terminals.
zinc ion binding Binding to a zinc ion (Zn).

8 GO annotations of biological process

Name Definition
cardiac left ventricle morphogenesis The process in which the left cardiac ventricle is generated and organized.
insulin processing The formation of mature insulin by proteolysis of the precursor preproinsulin. The signal sequence is first cleaved from preproinsulin to form proinsulin; proinsulin is then cleaved to release the C peptide, leaving the A and B chains of mature insulin linked by disulfide bridges.
peptide hormone secretion The regulated release of a peptide hormone from a cell.
peptide metabolic process The chemical reactions and pathways involving peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another.
protein localization to membrane A process in which a protein is transported to, or maintained in, a specific location in a membrane.
protein localization to secretory granule A process in which a protein is transported to, or maintained in, a location within a secretory granule.
protein processing Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein.
Wnt signaling pathway The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state.

16 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q2KJ83 CPN1 Carboxypeptidase N catalytic chain Bos taurus (Bovine) PR
Q8QGP3 CPZ Carboxypeptidase Z Gallus gallus (Chicken) PR
Q8IUX7 AEBP1 Adipocyte enhancer-binding protein 1 Homo sapiens (Human) PR
O75976 CPD Carboxypeptidase D Homo sapiens (Human) PR
Q8N436 CPXM2 Inactive carboxypeptidase-like protein X2 Homo sapiens (Human) PR
Q66K79 CPZ Carboxypeptidase Z Homo sapiens (Human) PR
Q96SM3 CPXM1 Probable carboxypeptidase X1 Homo sapiens (Human) PR
P14384 CPM Carboxypeptidase M Homo sapiens (Human) PR
Q80V42 Cpm Carboxypeptidase M Mus musculus (Mouse) PR
O89001 Cpd Carboxypeptidase D Mus musculus (Mouse) PR
Q9JJN5 Cpn1 Carboxypeptidase N catalytic chain Mus musculus (Mouse) PR
Q9Z100 Cpxm1 Probable carboxypeptidase X1 Mus musculus (Mouse) PR
Q9D2L5 Cpxm2 Inactive carboxypeptidase-like protein X2 Mus musculus (Mouse) PR
Q640N1 Aebp1 Adipocyte enhancer-binding protein 1 Mus musculus (Mouse) PR
Q9EQV8 Cpn1 Carboxypeptidase N catalytic chain Rattus norvegicus (Rat) PR
A2RUV9 Aebp1 Adipocyte enhancer-binding protein 1 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MARRGGCALL VLCGSLAACA WLLGAEARGP GGPVAGARRR RRPQEDGISF EYHRYPELRE
70 80 90 100 110 120
ALVSVWLQCA AVSRIYTVGR SFEGRELLVL ELSDNPGVHE PGEPEFKYIG NMHGNEAVGR
130 140 150 160 170 180
ELLIFLAQYL CNEYQKGNET IVQLIHNTRI HIMPSLNPDG FEKAASQLGE LKDWFVGRSN
190 200 210 220 230 240
AQGIDLNRNF PDLDRIVYIN EKEGGPNNHL LKNLKKIVDQ NTKLAPETKA VIHWIMDIPF
250 260 270 280 290 300
VLSANLHGGD LVANYPYDET RSGSAHEYSS CPDDDIFQSL ARAYSSFNPP MSDPDRPPCR
310 320 330 340 350 360
KNDDDSSFVE GTTNGAAWYS VPGGMQDFNY LSSNCFEITV ELSCEKFPPE ETLKNYWEDN
370 380 390 400 410 420
KNSLISYIQQ IHRGVKGFVR DLQGNPIANA TLSVEGIDHD VTSAKDGDYW RLLVPGNYKL
430 440 450 460 470
TASAPGYLAI AKKVAVPYSP AVRVDFELES FSERKEEEKE ELMEWWKMMS ETLNF